Cargando…
Emerging Options for the Management of Non-Small Cell Lung Cancer
Lung cancer is one of the leading causes of death in industrialized and developing countries. Approximately 80% of patients are diagnosed with non-small cell histology. Although a multidisciplinary approach is necessary for the treatment of patients at early or locally-advanced stages of the disease...
Autores principales: | Binder, Daniel, Hegenbarth, Karin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813617/ https://www.ncbi.nlm.nih.gov/pubmed/24179413 http://dx.doi.org/10.4137/CMO.S10269 |
Ejemplares similares
-
Therapeutic management options for stage III non-small cell lung cancer
por: Yoon, Stephanie M, et al.
Publicado: (2017) -
New options in the management of intractable ALK(+) metastatic non-small-cell lung cancer
por: Weise, Amy M, et al.
Publicado: (2014) -
Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options
por: Petrella, Francesco, et al.
Publicado: (2023) -
Therapeutical Options in ROS1—Rearranged Advanced Non Small Cell Lung Cancer
por: Stanzione, Brigida, et al.
Publicado: (2023) -
Emerging therapies for non-small cell lung cancer
por: Zhang, Chao, et al.
Publicado: (2019)